Artemis Therapeutics Inc.
OTC: ATMS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Shimon Citron
- Employees
- 4
- Headquarters
- New York City, United States
- IPO year
- 1998
- Market cap
- $55.8M
- Website
- https://www.artemis-therapeutics.com
Loading ATMS…
Loading profile data…Frequently asked questions about ATMS
What does Artemis Therapeutics Inc. (ATMS) do?
Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Where does ATMS trade?
Artemis Therapeutics Inc. (ATMS) trades on the Other OTC.
What sector is ATMS in?
Artemis Therapeutics Inc. (ATMS) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Artemis Therapeutics Inc.?
Shimon Citron is the chief executive officer of Artemis Therapeutics Inc. (ATMS).
Where is Artemis Therapeutics Inc. headquartered?
Artemis Therapeutics Inc. is headquartered in United States.
Does ATMS pay a dividend?
Artemis Therapeutics Inc. (ATMS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATMS go public?
Artemis Therapeutics Inc. (ATMS) completed its initial public offering in 1998.